What to Expect When Systemic Treatment in Juvenile Idiopathic Arthritis Is Withdrawn?

Juan Carlos Nieto-Gonzalez Daniel ClementeAlina BoteanuLaura Trives-FolgueraAntía García-FernándezPablo González NavarroJuan Carlos López RobledilloIndalecio Monteagudo-Saéz

Published in: The Journal of rheumatology (2023)

Flares are frequent when systemic treatment is withdrawn, and uveitis or joint injections could be related risk factors. In MTX and biologic-naïve patients, the frequency of flares occurred in more than half of patients, although they were less frequent when clinical remission lasted for > 1 year.

Keyphrases

juvenile idiopathic arthritis
end stage renal disease
ejection fraction
risk factors
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
rheumatoid arthritis
disease activity
ankylosing spondylitis
replacement therapy